HHS announced that it would distribute more than $100 million to states in a new initiative called The Medicaid Innovation Accelerator Program (IAP). The program intends to improve Medicaid programs and lower costs through technical support from the agency.
HHS announced that it would distribute more than $100 million to states in a new initiative called The Medicaid Innovation Accelerator Program (IAP). The program intends to improve Medicaid programs and lower costs through technical support from the agency. CMS said it would allow states to exchange best practices as well as strengthen states’ efforts to accelerate new payment and service delivery reform.
HHS Secretary Sylvia Burwell said IAP “will give states the opportunity to even further strengthen their great work,” adding that HHS “will provide strategically targeted resources that states can leverage to enhance the impact of their efforts to transform healthcare.”
CMS stated it would provide states with technical assistance in 4 specific areas:
The agency also noted that it has worked with states in a variety of other reform-focused programs such as the Healthcare Innovation Awards and the Strong Start initiative. These innovations have helped states to improve the quality of care and lower costs. However, innovation can be costly to sustain, and there have been many challenges with implementation. With programs like IAP, CMS can provide important resources and data support that supports state efforts.
“State lessons and recommendations spurred the formation of the IAP,” said a CMS release. “The IAP is designed to offer a new approach to addressing these challenges collaboratively, leveraging best practices in driving innovation in the public and private sectors.”
Around the Web
HHS Doles Out $100M to Spur Medicaid Innovation [Fierce Health Payer]
New Resources Improve States’ Abilities to Advance Medicaid Payment and Delivery System Reform [HHS]
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis
March 15th 2025The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the indication to include pediatric patients who are 6 years or older and positive for antiacetylcholine receptor antibodies.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More